A unique class of extracellular vesicles (EVs), exosomes range in size from 30 to 150 nm. They frequently travel to distant tissues inside an organism and are essential for cellular communication. Exosomes are useful in the creation of targeted therapeutics for the delivery of macromolecules and drug delivery systems because of their notable natural cell-targeting properties. Because of these features, exosomes are becoming more and more recognized as bio-derived vehicles for delivering and protecting therapeutic agents to treat various kinds of cancers (lung, pancreatic, colon, brain, and breast), viral diseases (AIDS, hepatitis B), and bacterial infections (toxoplasmosis, salmonellosis). According to research, the natural payload of exosomes can either exacerbate or lessen the severity of an illness. This calls for meticulous planning, which includes determining the exosomes' composition and source. As a result, approaches for assessing the features of intact exosomes as well as dependable and economical ways for isolating them are essential. However, several obstacles prevent them from being used in therapeutic settings. Exosome stabilization, safe and effective manufacture in large enough quantities, effective loading of therapeutic drugs into them, maximizing their removal from circulation, and scaling up production from research to clinical settings are some of these. A better comprehension of the molecular processes controlling exosome transport and activity is crucial for clinical applications. This review focuses on methods for isolating and characterizing exosomes, explores their potential as drug delivery platforms, and examines strategies to enhance therapeutic outcomes and improve their stability.
Read full abstract